Publication: Apocrine carcinomas of the breast in Turkish women: Hormone receptors, c-erbB-2 and p53 immunoexpression
| dc.contributor.author | KAYA, HANDAN | |
| dc.contributor.authors | Kaya, Handan; Bozkurt, Sueheyla Uyar; Erbarut, Ipek; Djamgoz, Mustafa B. A. | |
| dc.date.accessioned | 2022-03-12T17:34:11Z | |
| dc.date.available | 2022-03-12T17:34:11Z | |
| dc.date.issued | 2008 | |
| dc.description.abstract | The aims of this study were twofold: (i) to determine the occurrence frequency of apocrine carcinoma of the breast (ApBCa) in Turkish breast cancer (BCa) patients; and (ii) to evaluate the expression of estrogen receptor (ER), progesterone receptor (PR), androgen receptor (AR), gross cystic disease protein-15 (GCDFP-15), c-erbB-2, and p53 in these cases. Six hundred and twenty-six cases of BCa were studied immunohistochemically (streptoavidin-biotin horseradish peroxidase method). The results of ApBCa were compared with those of invasive ductal carcinoma not otherwise specified type (IDC-NOS) cases of similar grade. Thirteen cases of ApBCa were encountered, accounting for 2.1% of all BCa cases. Immunohistochemically, ApBCa positivity was as follows: GCDFP-15 (100%), ER (39%), PR (8%), AR (54%), p53 (39%), and c-erbB-2 (85%). In the IDC-NOS group, GCDFP-15* was expressed in less than 50% of the tumors. The occurrence frequencies of the other markers were as follows: ER (69%), PR (69%)*, AR (46%), c-erbB-2 (0%)*, and p53 (31%), (*) indicating significant differences between the two groups. For Turkish BCa patients, (i) the occurrence rate of ApBCa (2.1%) was high; and (ii) the following combination would allow for an immunohistochemical identification of ApBCa: GCDFP-15(+), c-erbB-2(+), and PR-. (C) 2008 Elsevier GmbH. All rights reserved. | |
| dc.identifier.doi | 10.1016/j.prp.2008.01.012 | |
| dc.identifier.issn | 0344-0338 | |
| dc.identifier.pubmed | 18342452 | |
| dc.identifier.uri | https://hdl.handle.net/11424/228981 | |
| dc.identifier.wos | WOS:000257025500002 | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER GMBH | |
| dc.relation.ispartof | PATHOLOGY RESEARCH AND PRACTICE | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | apocrine carcinoma | |
| dc.subject | breast | |
| dc.subject | hormone receptor | |
| dc.subject | oncogene | |
| dc.subject | PROGESTERONE-RECEPTOR | |
| dc.subject | ESTROGEN-RECEPTOR | |
| dc.subject | IMMUNOHISTOCHEMICAL ANALYSIS | |
| dc.subject | ANDROGEN RECEPTORS | |
| dc.subject | EXPRESSION | |
| dc.subject | MUTATIONS | |
| dc.subject | FREQUENCY | |
| dc.subject | PATHOLOGY | |
| dc.subject | CANCER | |
| dc.subject | AGE | |
| dc.title | Apocrine carcinomas of the breast in Turkish women: Hormone receptors, c-erbB-2 and p53 immunoexpression | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| local.avesis.id | 0e4e4e6a-75af-497c-bb0a-c486cb54c2ed | |
| local.import.package | SS17 | |
| local.indexed.at | WOS | |
| local.indexed.at | SCOPUS | |
| local.indexed.at | PUBMED | |
| local.journal.numberofpages | 5 | |
| oaire.citation.endPage | 371 | |
| oaire.citation.issue | 6 | |
| oaire.citation.startPage | 367 | |
| oaire.citation.title | PATHOLOGY RESEARCH AND PRACTICE | |
| oaire.citation.volume | 204 | |
| relation.isAuthorOfPublication | 0bf301ff-2544-4a5e-b38b-b43084d6c255 | |
| relation.isAuthorOfPublication.latestForDiscovery | 0bf301ff-2544-4a5e-b38b-b43084d6c255 |